149 related articles for article (PubMed ID: 22492281)
41. [Relationship of epidermal growth factor receptor gene mutations, clinicopathologic features and prognosis in patients with non-small cell lung cancer].
Fan MJ; Li HG; Lü ZQ; Zhang HZ; Shen XM
Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):679-82. PubMed ID: 22321547
[TBL] [Abstract][Full Text] [Related]
42. The presence of mutations in epidermal growth factor receptor gene is not a prognostic factor for long-term outcome after surgical resection of non-small-cell lung cancer.
Kim YT; Seong YW; Jung YJ; Jeon YK; Park IK; Kang CH; Kim JH
J Thorac Oncol; 2013 Feb; 8(2):171-8. PubMed ID: 23287850
[TBL] [Abstract][Full Text] [Related]
43. Association of diffuse, random pulmonary metastases, including miliary metastases, with epidermal growth factor receptor mutations in lung adenocarcinoma.
Togashi Y; Masago K; Kubo T; Sakamori Y; Kim YH; Hatachi Y; Fukuhara A; Mio T; Togashi K; Mishima M
Cancer; 2011 Feb; 117(4):819-25. PubMed ID: 20886633
[TBL] [Abstract][Full Text] [Related]
44. EGFR mutation status in primary lung adenocarcinomas and corresponding metastatic lesions: discordance in pleural metastases.
Han HS; Eom DW; Kim JH; Kim KH; Shin HM; An JY; Lee KM; Choe KH; Lee KH; Kim ST; Koo JH; Lee HC; Lee OJ
Clin Lung Cancer; 2011 Nov; 12(6):380-6. PubMed ID: 21729655
[TBL] [Abstract][Full Text] [Related]
45. Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancer.
Tomizawa Y; Iijima H; Sunaga N; Sato K; Takise A; Otani Y; Tanaka S; Suga T; Saito R; Ishizuka T; Dobashi K; Minna JD; Nakajima T; Mori M
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6816-22. PubMed ID: 16203769
[TBL] [Abstract][Full Text] [Related]
46. Q787Q EGFR Polymorphism as a Prognostic Factor for Lung Squamous Cell Carcinoma.
Koh YW; Kim HJ; Kwon HY; Han JH; Lee CK; Lee MS; Kim CJ; Baek MJ; Jeong D
Oncology; 2016; 90(5):289-98. PubMed ID: 26999786
[TBL] [Abstract][Full Text] [Related]
47. Advanced adenocarcinoma of the lung: comparison of CT characteristics of patients with anaplastic lymphoma kinase gene rearrangement and those with epidermal growth factor receptor mutation.
Choi CM; Kim MY; Hwang HJ; Lee JB; Kim WS
Radiology; 2015 Apr; 275(1):272-9. PubMed ID: 25575117
[TBL] [Abstract][Full Text] [Related]
48. Angiogenesis of lung cancer utilizes existing blood vessels rather than developing new vessels using signals from carcinogenesis.
Uramoto H; Yamada S; Tanaka F
Anticancer Res; 2013 May; 33(5):1913-6. PubMed ID: 23645738
[TBL] [Abstract][Full Text] [Related]
49. Incidence of EGFR exon 19 deletions and L858R in tumor specimens from men and cigarette smokers with lung adenocarcinomas.
D'Angelo SP; Pietanza MC; Johnson ML; Riely GJ; Miller VA; Sima CS; Zakowski MF; Rusch VW; Ladanyi M; Kris MG
J Clin Oncol; 2011 May; 29(15):2066-70. PubMed ID: 21482987
[TBL] [Abstract][Full Text] [Related]
50. Promoter methylation of RASSF1A and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokers.
Liu Y; Gao W; Siegfried JM; Weissfeld JL; Luketich JD; Keohavong P
BMC Cancer; 2007 May; 7():74. PubMed ID: 17477876
[TBL] [Abstract][Full Text] [Related]
51. Patterns of EGFR, HER2, TP53, and KRAS mutations of p14arf expression in non-small cell lung cancers in relation to smoking history.
Mounawar M; Mukeria A; Le Calvez F; Hung RJ; Renard H; Cortot A; Bollart C; Zaridze D; Brennan P; Boffetta P; Brambilla E; Hainaut P
Cancer Res; 2007 Jun; 67(12):5667-72. PubMed ID: 17575133
[TBL] [Abstract][Full Text] [Related]
52. The Association of EGFR Mutations with Stage at Diagnosis in Lung Adenocarcinomas.
Cho J; Choi SM; Lee J; Lee CH; Lee SM; Yim JJ; Chung DH; Yoo CG; Kim YW; Han SK; Park YS
PLoS One; 2016; 11(11):e0166821. PubMed ID: 27861565
[TBL] [Abstract][Full Text] [Related]
53. Serum carcinoembryonic antigen levels before initial treatment are associated with EGFR mutations and EML4- ALK fusion gene in lung adenocarcinoma patients.
Wang WT; Li Y; Ma J; Chen XB; Qin JJ
Asian Pac J Cancer Prev; 2014; 15(9):3927-32. PubMed ID: 24935562
[TBL] [Abstract][Full Text] [Related]
54. Clinical characteristics of patients with non-small cell lung cancers harboring anaplastic lymphoma kinase rearrangements and primary lung adenocarcinoma harboring epidermal growth factor receptor mutations.
Xu L; Lei J; Wang QZ; Li J; Wu L
Genet Mol Res; 2015 Oct; 14(4):12973-83. PubMed ID: 26505450
[TBL] [Abstract][Full Text] [Related]
55. Epidermal growth factor receptor abnormalities in the pathogenesis and progression of lung adenocarcinomas.
Tang X; Varella-Garcia M; Xavier AC; Massarelli E; Ozburn N; Moran C; Wistuba II
Cancer Prev Res (Phila); 2008 Aug; 1(3):192-200. PubMed ID: 19138956
[TBL] [Abstract][Full Text] [Related]
56. Coexistence of p16/CDKN2A homozygous deletions and activating EGFR mutations in lung adenocarcinoma patients signifies a poor response to EGFR-TKIs.
Jiang J; Gu Y; Liu J; Wu R; Fu L; Zhao J; Guan Y
Lung Cancer; 2016 Dec; 102():101-107. PubMed ID: 27987577
[TBL] [Abstract][Full Text] [Related]
57. Epidermal Growth Factor Receptor Gene Mutation in Pleural Lavage Cytology Findings of Primary Lung Adenocarcinoma Cases.
Inoue T; Matsumura Y; Araki O; Karube Y; Maeda S; Kobayashi S; Chida M
Ann Thorac Cardiovasc Surg; 2018 Feb; 24(1):1-5. PubMed ID: 29093430
[TBL] [Abstract][Full Text] [Related]
58. Association of p16 homozygous deletions with clinicopathologic characteristics and EGFR/KRAS/p53 mutations in lung adenocarcinoma.
Iwakawa R; Kohno T; Anami Y; Noguchi M; Suzuki K; Matsuno Y; Mishima K; Nishikawa R; Tashiro F; Yokota J
Clin Cancer Res; 2008 Jun; 14(12):3746-53. PubMed ID: 18559592
[TBL] [Abstract][Full Text] [Related]
59. Common cancer-driver mutations and their association with abnormally methylated genes in lung adenocarcinoma from never-smokers.
Tessema M; Rossi MR; Picchi MA; Yingling CM; Lin Y; Ramalingam SS; Belinsky SA
Lung Cancer; 2018 Sep; 123():99-106. PubMed ID: 30089603
[TBL] [Abstract][Full Text] [Related]
60. Epidermal growth factor receptor and K-RAS mutations in 411 lung adenocarcinoma: a population-based prospective study.
Boldrini L; Alì G; Gisfredi S; Ursino S; Baldini E; Melfi F; Lucchi M; Comin CE; Maddau C; Tibaldi C; Camacci T; Servadio A; Mussi A; Fontanini G
Oncol Rep; 2009 Oct; 22(4):683-91. PubMed ID: 19724844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]